USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$376.26M
Market Cap
-
P/E Ratio
-5.4
EPS
$24.75
52 Week High
$4.38
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1.5M |
Total Revenue | $1.7M |
Cost Of Revenue | $149K |
Costof Goods And Services Sold | $149K |
Operating Income | -$29M |
Selling General And Administrative | $12M |
Research And Development | $19M |
Operating Expenses | $30M |
Investment Income Net | - |
Net Interest Income | -$8.3M |
Interest Income | $1.5M |
Interest Expense | $9.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $226K |
Income Before Tax | -$34M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$34M |
Comprehensive Income Net Of Tax | - |
Ebit | -$25M |
Ebitda | -$24M |
Net Income | -$34M |
Field | Value (USD) |
---|---|
Total Assets | $25M |
Total Current Assets | $21M |
Cash And Cash Equivalents At Carrying Value | $20M |
Cash And Short Term Investments | $20M |
Inventory | - |
Current Net Receivables | $507K |
Total Non Current Assets | $3.9M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $747K |
Other Non Current Assets | - |
Total Liabilities | $64M |
Total Current Liabilities | $4.8M |
Current Accounts Payable | $1.5M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $375K |
Total Non Current Liabilities | $59M |
Capital Lease Obligations | $703K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $52M |
Other Current Liabilities | $3M |
Other Non Current Liabilities | $52M |
Total Shareholder Equity | -$39M |
Treasury Stock | - |
Retained Earnings | -$355M |
Common Stock | $77K |
Common Stock Shares Outstanding | $74M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$25M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $226K |
Capital Expenditures | $977K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$638K |
Cashflow From Financing | $16M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$34M |
Field | Value (USD) |
---|---|
Gross Profit | $1.5M |
Total Revenue | $1.7M |
Cost Of Revenue | $149K |
Costof Goods And Services Sold | $149K |
Operating Income | -$29M |
Selling General And Administrative | $12M |
Research And Development | $19M |
Operating Expenses | $30M |
Investment Income Net | - |
Net Interest Income | -$8.3M |
Interest Income | $1.5M |
Interest Expense | $9.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $226K |
Income Before Tax | -$34M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$34M |
Comprehensive Income Net Of Tax | - |
Ebit | -$25M |
Ebitda | -$24M |
Net Income | -$34M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Clearside Biomedical, Inc., a biopharmaceutical company, is dedicated to developing and delivering treatments that restore and preserve vision for people with serious eye diseases. The company is headquartered in Alpharetta, Georgia.